Patents for C12R 1 - Micro-organisms (92,025)
08/2000
08/10/2000WO2000046388A1 Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth
08/10/2000WO2000046353A1 Sebocytes, sebocyte cell lines and applications thereof
08/10/2000WO2000046351A2 Platform for the differentiation of cells
08/10/2000WO2000046349A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/10/2000WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
08/10/2000WO2000046175A1 Microbial process for preparing pravastatin
08/10/2000WO2000045840A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
08/10/2000WO2000045640A1 Pesticidal use of a parasitic flagellate for eliminating or suppressing harmful algae blooms
08/10/2000WO2000045633A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor
08/10/2000WO2000010584A9 Method for detection of legionella bacteria employing purified antigen-specific antibodies
08/10/2000DE19905069A1 Nucleinsäuremoleküle codierend Alternansucrase Nucleic acid molecules encoding alternansucrase
08/10/2000DE19903920A1 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses
08/10/2000DE10003096A1 Kulturmedium zum Züchten von Lactobacillus Clearans und Verfahren zum Konservieren dieses Stamms Culture medium for the growth of Lactobacillus Clearans and method for preserving this strain
08/10/2000CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000CA2360840A1 Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth
08/10/2000CA2359821A1 Platform for the differentiation of cells
08/10/2000CA2359469A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
08/09/2000EP1026262A2 Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
08/09/2000EP1026256A2 Method for the production of optically active cyanohydrins
08/09/2000EP1026255A1 Process for preparing xylitol
08/09/2000EP1026254A1 Process for preparing xylitol
08/09/2000EP1026251A2 Transgenic animals expressing human P25
08/09/2000EP1026250A1 DNA-constructs of blood clotting factors and P-selectin
08/09/2000EP1026246A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
08/09/2000EP1026241A1 An improved method for preparing DNA from serum and plasma
08/09/2000EP1026240A2 Generation and selection of recombinant varied binding proteins
08/09/2000EP1026239A2 A new method for tapping the immunological repertoire
08/09/2000EP1026238A2 Cloned glutamic acid decarboxylase
08/09/2000EP1026235A1 Levodione reductase
08/09/2000EP1026173A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same
08/09/2000EP1025255A1 Method for preparing a substituted benzamide
08/09/2000EP1025242A1 A method of inhibiting an immune response to a recombinant vector
08/09/2000EP1025241A2 Multiply-substituted protease variants
08/09/2000EP1025240A2 Multiply-substituted protease variants with altered net charge for use in detergents
08/09/2000EP1025239A2 Multiply-substituted protease variants
08/09/2000EP1025213A1 Epoxide hydrolase
08/09/2000EP1025211A2 Hyaluronan synthase gene and uses thereof
08/09/2000EP1025194A1 Bleaching compositions comprising multiply-substituted protease variants
08/09/2000EP1025052A1 Method for reducing the effect of detergents upon germination and/or growth of microorganisms
08/09/2000EP1024828A1 NOVEL pheS (BETA)
08/09/2000EP1024827A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
08/09/2000EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses
08/09/2000EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
08/09/2000EP0568645B1 Mixed specificity fusion proteins
08/09/2000EP0556171B1 Growth hormone antagonists
08/09/2000CN1055314C Cloning and over expression of glucose-6-phosphate dehydrogenase fro leuconostoc dextranicus
08/08/2000US6100446 Plant cell transformed with nucleotide sequences which code a degratory enzymatic protein; for pollution control
08/08/2000US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals
08/08/2000US6100376 A21, B30, modified insulin derivatives having an altered action profile
08/08/2000US6100241 Nucleic acids encoding an immunogenic fragment of eimeria lactate dehydrogenase (ldh) which will react with antiserum raised against the ldh; preparing a vector vaccine against coccidiosis; administering to prevent coccidiosis in birds
08/08/2000US6100235 Methods of treating immune and inflammatory response with IL-17 receptors
08/08/2000US6100088 Viral vaccines
08/08/2000US6100078 Purified DNA polymerase from bacillus stearothermophilus ATCC 12980
08/08/2000US6100076 Amino acid sequence of enzyme which glycosylates an epidermal growth factor domain of a polypeptide with an activated fucose moiety
08/08/2000US6100073 Acid-stable and thermo-stable enzymes derived from sulfolobus species
08/08/2000US6100065 Recombinant polypeptide particles with high immunogenicity; comprises portion of pre-s1 peptide and surface antigen peptide
08/08/2000US6100057 Introducing regulatory sequences which link to endogenous heme biosynthetic enzymes or copies of nucleotide sequences encoding heme biosynthetic enzymes with linked regulatory sequences, culturing fungus, recovering secreted hemoprotein
08/08/2000US6100053 Microbial transglutaminases, their production and use
08/08/2000US6100052 Culturing strain of streptomyces clavuligerus in medium having initial soluble phosphate concentration of 150 and 600 mg/l, maintaining concentration between 20 and 150 mg/l by adding or removing soluble phosphate, isolating product
08/08/2000US6099842 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
08/08/2000US6099840 Variant hbsag protein of fragment thereof displaying the antigenicity of hepatitis b virus surface antigen
08/08/2000US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases
08/08/2000US6099833 Method for inhibiting production of toxins from enteropathogenic escherichia coli, and butyric-acid bacteria and butyric-acid bacteria containing pharmaceuticals used in combination with antibiotics for the method
08/08/2000CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle
08/08/2000CA2216165C Ndf peptides
08/08/2000CA2149764C Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
08/08/2000CA2125376C Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
08/08/2000CA2071907C Bcrf1 proteins as inhibitors of interferon-y
08/08/2000CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function
08/08/2000CA1341079C Large scale method for purification of high purity heparinase
08/08/2000CA1341074C Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine
08/08/2000CA1341073C Vectors and methods for expression of human protein c activity
08/03/2000WO2000045176A2 METHOD OF IDENTIFYING N-TERMINAL proBNP
08/03/2000WO2000044923A1 Biocatalytic synthesis of shikimic acid
08/03/2000WO2000044899A1 Her-2/neu fusion proteins
08/03/2000WO2000044883A1 Propagation of bovine coronavirus in chinese hamster ovary cells
08/03/2000WO2000044772A2 Human serum albumin
08/03/2000WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens
08/03/2000WO2000044230A1 A method of controlling fungal pathogens, and agents useful for same
08/03/2000WO2000037614A3 Variants of egiii-like cellulase and compositions thereof
08/03/2000WO2000024878A3 Mutant luciferase having increased thermostability
08/03/2000WO2000020609A3 Protective recombinant haemophilus influenzae high molecular weight proteins
08/03/2000WO2000014240A3 Attenuated salmonella sp12 mutants as antigen carriers
08/03/2000WO2000010593A9 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS
08/03/2000WO2000009691A9 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
08/03/2000WO2000009669A9 Human mesencephalon cell lines and methods of use therefor
08/03/2000WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them
08/03/2000WO2000009018A9 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
08/03/2000WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof
08/03/2000DE19903095A1 Gewinnung von gamma-Linolensäure aus Protozoen der Gattung Colpidium Production of gamma-linolenic acid from protozoa of the genus Colpidium
08/03/2000CA2361246A1 Identification of specific differentially expressed antigens
08/03/2000CA2360600A1 A method of controlling fungal pathogens, and agents useful for same
08/02/2000EP1024199A2 Recovery of gamma-linolenic acid from protozoa of the genus Colpidium
08/02/2000EP1024197A2 Mesothelial cell gene therapy
08/02/2000EP1024191A2 Production of chimeric antibodies from antibody segment repertoires and displayed on phage
08/02/2000EP1024189A1 Novel antigenic class of avian reoviruses
08/02/2000EP1024145A2 Novel azalides and methods of making same
08/02/2000EP1023903A1 Use of life attenuated bacteria for the manufacture of a submucosal vaccine
08/02/2000EP1023462A1 ZOOGLOEAL AND $i(HYPHOMICROBIUM) SPP. NUCLEIC ACIDS
08/02/2000EP1023438A1 Expression of starch-binding domain (sbd)